These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11858958)

  • 1. The EORTC Laboratory Research Division. European Organisation for Research and Treatment of Cancer.
    Brünner N; Double J; Fichtner I; Gescher A; Newell D; Oosterhuis W; Price P
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S14-8. PubMed ID: 11858958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EORTC and drug development. European Organisation for Research and Treatment of Cancer.
    Lacombe D; Fumoleau P; Zwierzina H; Twelves C; Hakansson L; Jayson G; Lehmann F; Verweij J; ;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S19-23. PubMed ID: 11858959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EORTC Melanoma Group: a comprehensive melanoma research programme by clinicians and scientists. European Organisation for Research and Treatment of Cancer.
    Eggermont AM; Keilholz U; Autier P; Ruiter DJ; Lehmann F; Lienard D;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S114-9. PubMed ID: 11858976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer drug development in Europe: a selection of new agents under development at the European Drug Development Network.
    Lacombe D; Butler-Smith A; Therasse P; Fumoleau P; Burtles S; Calvert H; Marsoni S; Sessa C; Verweij J
    Cancer Invest; 2003; 21(1):137-47. PubMed ID: 12643015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing the challenge of intergroup studies in oncology: the EORTC experience. European Organisation for Research and Treatment of Cancer.
    Zurlo A; Therasse P
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S169-72. PubMed ID: 11858988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer.
    Fayers P; Bottomley A; ;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S125-33. PubMed ID: 11858978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EORTC clinical research coordinators group. European Organisation for Research and Treatment of Cancer.
    Fishwick K; Berridge J; Coffey M; Colussi AM; Di Giulio P; Marinus A; Molin C; Peters M
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S54-9. PubMed ID: 11858966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 40 years of the EORTC: the evolution towards a unique network to develop new standards of cancer care. European Organisation for Research and Treatment of Cancer.
    Meunier F; van Oosterom AT
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S3-13. PubMed ID: 11858957
    [No Abstract]   [Full Text] [Related]  

  • 9. Allan van Oosterom, President of the EORTC. European Organisation for the Research and Treatment of Cancer. Interview by Jeroen van der Boon.
    van Oosterom A
    Lancet Oncol; 2002 Jan; 3(1):58-61. PubMed ID: 11905607
    [No Abstract]   [Full Text] [Related]  

  • 10. Scientific review of EORTC trials: the functioning of the New Treatment Committee and Protocol Review Committee.
    Lardot C; Steward W; Van Glabbeke M; Armand JP
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S24-30. PubMed ID: 11858960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EORTC Brain Tumor Group: achievements and perspectives.
    Vecht ChJ; van den Bent MJ; Lacombe D
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S35-8. PubMed ID: 11858962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EORTC Boron Neutron Capture Therapy (BNCT) Group: achievements and future projects.
    Sauerwein W; Zurlo A;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S31-4. PubMed ID: 11858961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory issues for clinical trials at EORTC: the way forward. European Organisation for Research and Treatment of Cancer.
    Baeyens AJ; Lacombe D
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S142-6. PubMed ID: 11858981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EORTC Breast Cancer Group: 40 years of research contributing to improve breast cancer management.
    Therasse P; Piccart M; van de Velde CJ; Jassem J;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S39-43. PubMed ID: 11858963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary: fifty years of the European Organisation for Research and Treatment Of Cancer (EORTC)--making the difference for the European oncology community.
    Meunier F; Lawler M; Pinedo HM
    Oncologist; 2012; 17(6):e6-7. PubMed ID: 22723021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Economics Unit achievements.
    Crott R; Neymark N
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S147-50. PubMed ID: 11858982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the EORTC pathologist in clinical trials: achievements and perspectives. European Organisation for Research and Treatment of Cancer.
    Spatz A; Ruiter DJ; Busch C; Theodorovic I; Oosterhuis JW
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S120-4. PubMed ID: 11858977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EORTC Gastrointestinal Tract Cancer Group: 40 years of research contributing to improved GI cancer management.
    Anak O; Van Cutsem E; Nordlinger B
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S65-70. PubMed ID: 11858968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highlights and strategies of the EORTC Leukemia Group. European Organisation for Research and Treatment of Cancer.
    de Witte T; Marie JP; Suciu S; Anak O;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S94-9. PubMed ID: 11858973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EORTC Radiotherapy Group: achievements and future projects. European Organisation for Research and Treatment of Cancer.
    Budach V; Zurlo A; Horiot JC
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S134-7. PubMed ID: 11858979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.